| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/2011 | CN101475634B Extracting method for plant chloroplast total protein |
| 06/22/2011 | CN101456904B Rhamnose bacterium lacticum Pr2 peptide and coding gene thereof, separation method and application |
| 06/22/2011 | CN101148671B Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
| 06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 06/22/2011 | CN101115767B vWFA and/or ANT_IG domain containing proteins |
| 06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/21/2011 | US7964773 Of given amino acid sequence; transforming plants to be resistant to insects and larvae |
| 06/21/2011 | US7964769 Using vector transfromation to generate transgenic soybean seeds with enhanced concentrations of lipids, fatty acids, starches and storage proteins |
| 06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
| 06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 06/21/2011 | US7964709 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964576 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 06/21/2011 | US7964572 High affinity nucleic acid ligands of complement system proteins |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964563 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/21/2011 | US7964562 folliculogenesis and follicular maturation without ovarian hyperstimulation; contain various FSH-to-hCG ratios and a carrier; enable the practitioner to optimize ovulatory stimulation in flexible manner |
| 06/21/2011 | US7964559 MVL, an antiviral protein from a cyanobacterium |
| 06/21/2011 | US7964536 Neoepitope detection of disease using protein arrays |
| 06/21/2011 | US7964406 Means and methods for producing a stabilized cell of interest |
| 06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
| 06/21/2011 | US7964393 Constitutive promoter Lip3 |
| 06/21/2011 | US7964377 Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF |
| 06/21/2011 | US7964376 Chimeric proteins and their use in methods to screen for sweet taste modulators |
| 06/21/2011 | US7964375 Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964367 Human p51 genes and gene products thereof |
| 06/21/2011 | US7964358 Sphingosine 1-phosphate receptor gene, SPPR |
| 06/21/2011 | US7964197 Pathogen for bacterial poultry disease |
| 06/21/2011 | US7964196 Self-assembling nanoparticle drug delivery system |
| 06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
| 06/21/2011 | US7964190 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 06/21/2011 | US7964184 Cysteine variants of interferon-gamma |
| 06/21/2011 | US7964183 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 06/21/2011 | CA2505786C Methods for identifying risk of breast cancer and treatments thereof |
| 06/21/2011 | CA2470731C Corticotropin releasing factor 2 receptor agonists |
| 06/21/2011 | CA2455499C Method for purification of viral vectors having proteins which bind sialic acid |
| 06/21/2011 | CA2427088C Interferon-beta purification and recovery |
| 06/21/2011 | CA2413316C Genetically modified plants with heterogeneous proteinase inhibitor sapin2a and methods of use thereof for the inhibition of endogenous trypsin-and chymotrypsin-like activities |
| 06/21/2011 | CA2386471C Purification of recombinant proteins fused to multiple epitopes |
| 06/21/2011 | CA2376381C Server-assisted regeneration of a strong secret from a weak secret |
| 06/21/2011 | CA2342770C Ly6h gene |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2303460C Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/21/2011 | CA2280791C Immunological detection of prions |
| 06/21/2011 | CA2258735C Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 06/21/2011 | CA2250854C Methods for the diagnosis and prognosis of cancer |
| 06/21/2011 | CA2202873C Process for purification of factor viii |
| 06/21/2011 | CA2198966C Method for cleaving chimeric protein using processing enzyme |
| 06/21/2011 | CA2177734C Construction of pasteurella heamolytica vaccines |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/16/2011 | WO2011072288A2 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | WO2011072191A2 Protease variants |
| 06/16/2011 | WO2011072119A2 Stem-cell material and method of use |
| 06/16/2011 | WO2011071982A2 Synthesis of prazole compounds |
| 06/16/2011 | WO2011071957A1 Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
| 06/16/2011 | WO2011071799A2 Purification of bivalirudin |
| 06/16/2011 | WO2011071783A1 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/16/2011 | WO2011071480A1 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 06/16/2011 | WO2011071155A1 Method for detection of basic peptide and reagent for detection of basic peptide |
| 06/16/2011 | WO2011071083A1 Molecular probe for imaging of pancreatic islet, and use thereof |
| 06/16/2011 | WO2011071050A1 Stomate-increasing agent, polypeptide, method for increasing number and/or density of stomates in plant, and method for increasing yield of plant |
| 06/16/2011 | WO2011070214A2 Novel conjugates and compositions for immunotherapy and antineoplastic treatment |
| 06/16/2011 | WO2011070172A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/16/2011 | WO2011070150A1 Novel targets for the treatment of proliferative diseases |
| 06/16/2011 | WO2011070113A1 Sophorolipid transporter protein |
| 06/16/2011 | WO2011069992A2 Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target |
| 06/16/2011 | WO2011069643A2 Silk protein coatings |
| 06/16/2011 | WO2011069459A1 Seed-specific expression vector and its construction methods and applications |
| 06/16/2011 | WO2011069408A1 Polypeptide immunogen, preparation method and use thereof |
| 06/16/2011 | WO2011069280A1 Antimicrobial pexiganan analogue and preparation process thereof |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | WO2011069182A1 Compositions comprising zinc finger domains and uses therefor |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011047868A3 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions |
| 06/16/2011 | WO2011045232A3 Neuropeptide-2 receptor (y-2r) agonists |
| 06/16/2011 | WO2011045113A9 Competitive exclusion composition and methods |
| 06/16/2011 | WO2011042762A3 Insulin like peptides |
| 06/16/2011 | WO2011042516A3 Expression system |
| 06/16/2011 | WO2011039631A3 Expression of meningococcal fhbp polypeptides |
| 06/16/2011 | WO2011036640A3 Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations |
| 06/16/2011 | WO2011028344A3 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 06/16/2011 | WO2011017442A3 Anti-rsv immunogens and methods of immunization |
| 06/16/2011 | WO2011017162A9 Methods for enhancing antigen-specific immune responses |
| 06/16/2011 | WO2011017107A3 Microbubble assisted viral delivery |
| 06/16/2011 | WO2011011388A3 Neuregulin induced regeneraton of heart muscle muscle |
| 06/16/2011 | US20110145946 Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
| 06/16/2011 | US20110145944 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
| 06/16/2011 | US20110144313 Membrane fusion proteins derived from reovirus |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144307 Methods and Compositions Comprising Non-Natural Amino Acids |
| 06/16/2011 | US20110144306 Ligation of stapled polypeptides |
| 06/16/2011 | US20110144305 Gag binding protein |
| 06/16/2011 | US20110144302 Polypeptide |
| 06/16/2011 | US20110144281 Amphiphilic polymers having a cholane core |
| 06/16/2011 | US20110144186 Ssx-2 peptides presented by hla class ii molecules |